Page last updated: 2024-09-05

valiolamine and 2019 Novel Coronavirus Disease

valiolamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brown, AN; Franco, EJ; Hanrahan, KC; Hill, DC; Karade, SS; Kolesnikov, A; MacKerell, AD; Mariuzza, RA; Rojas, AC; Treston, AM; Weber, DJ; Yu, W	1

Other Studies

1 other study(ies) available for valiolamine and 2019 Novel Coronavirus Disease

Article	Year
Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity. Journal of medicinal chemistry, 2023, 02-23, Volume: 66, Issue:4 Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Antiviral Agents; COVID-19; Endoplasmic Reticulum; Glycoproteins; Glycoside Hydrolase Inhibitors; Quantitative Structure-Activity Relationship; SARS-CoV-2	2023

Article

Year

Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.

Journal of medicinal chemistry, 2023, 02-23, Volume: 66, Issue:4

Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Antiviral Agents; COVID-19; Endoplasmic Reticulum; Glycoproteins; Glycoside Hydrolase Inhibitors; Quantitative Structure-Activity Relationship; SARS-CoV-2

2023